Insider trades

Michael Schmertzler, Director of PTC Therapeutics PTCT, has filed 0 purchases and 2 sales on the open market. The latest trade was on 01/02.

Michael Schmertzler

Director
First filing
23/01/09
Trades
16 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
01/02

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan24/01/0824/01/101,500 sh$27.81$41,715−1.3%
Open-market sale10b5-1 plan23/06/0723/06/091,000 sh$44.86$44,860−0.8%